Australia's most trusted
source of pharma news
Friday, 26 April 2024
Posted 30 November 2021 PM
The first batch of Australia's homegrown mRNA COVID-19 vaccine has been successfully manufactured by IDT Australia in preparation for a human clinical trial.
While the researchers were hopeful for a November start, the Victoria State Government announced today (Tuesday) that the phase one trial, seeking to recruit 150 participants will "begin in the new year".
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.